12-109578754-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000431.4(MVK):​c.227-1048G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.169 in 152,152 control chromosomes in the GnomAD database, including 2,245 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.17 ( 2245 hom., cov: 33)

Consequence

MVK
NM_000431.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.752

Publications

16 publications found
Variant links:
Genes affected
MVK (HGNC:7530): (mevalonate kinase) This gene encodes the peroxisomal enzyme mevalonate kinase. Mevalonate is a key intermediate, and mevalonate kinase a key early enzyme, in isoprenoid and sterol synthesis. Mevalonate kinase deficiency caused by mutation of this gene results in mevalonic aciduria, a disease characterized psychomotor retardation, failure to thrive, hepatosplenomegaly, anemia and recurrent febrile crises. Defects in this gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
MVK Gene-Disease associations (from GenCC):
  • porokeratosis 3, disseminated superficial actinic type
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hyperimmunoglobulinemia D with periodic fever
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • mevalonic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • disseminated superficial actinic porokeratosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • porokeratosis of Mibelli
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.183 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000431.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MVK
NM_000431.4
MANE Select
c.227-1048G>A
intron
N/ANP_000422.1
MVK
NM_001414512.1
c.227-1048G>A
intron
N/ANP_001401441.1
MVK
NM_001114185.3
c.227-1048G>A
intron
N/ANP_001107657.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MVK
ENST00000228510.8
TSL:1 MANE Select
c.227-1048G>A
intron
N/AENSP00000228510.3
MVK
ENST00000546277.6
TSL:5
c.227-1048G>A
intron
N/AENSP00000438153.2
MVK
ENST00000636996.1
TSL:5
c.218+2609G>A
intron
N/AENSP00000490869.1

Frequencies

GnomAD3 genomes
AF:
0.169
AC:
25704
AN:
152034
Hom.:
2249
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.187
Gnomad AMI
AF:
0.216
Gnomad AMR
AF:
0.157
Gnomad ASJ
AF:
0.191
Gnomad EAS
AF:
0.140
Gnomad SAS
AF:
0.132
Gnomad FIN
AF:
0.0989
Gnomad MID
AF:
0.174
Gnomad NFE
AF:
0.175
Gnomad OTH
AF:
0.171
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.169
AC:
25711
AN:
152152
Hom.:
2245
Cov.:
33
AF XY:
0.163
AC XY:
12162
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.187
AC:
7745
AN:
41498
American (AMR)
AF:
0.157
AC:
2394
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.191
AC:
663
AN:
3468
East Asian (EAS)
AF:
0.140
AC:
723
AN:
5176
South Asian (SAS)
AF:
0.130
AC:
627
AN:
4822
European-Finnish (FIN)
AF:
0.0989
AC:
1047
AN:
10584
Middle Eastern (MID)
AF:
0.170
AC:
50
AN:
294
European-Non Finnish (NFE)
AF:
0.175
AC:
11898
AN:
68004
Other (OTH)
AF:
0.174
AC:
367
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1121
2242
3362
4483
5604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.172
Hom.:
378
Bravo
AF:
0.176
Asia WGS
AF:
0.151
AC:
524
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.56
DANN
Benign
0.61
PhyloP100
-0.75
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4766613; hg19: chr12-110016559; API